Evaluation of a Voice-Activated Call Light System for Clients With Limited Upper-Extremity Mobility
Public ClinicalTrials.gov record NCT07873151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this study is to evaluate whether a voice-activated call light system enables people in a rehabilitation facility who have limited use of their arms and hands to call for help more independently and reliably than with their previous call light access method. The study will also examine client confidence, family confidence and peace of mind, staff confidence, staff effort, system reliability, and the level of disruption to routine care. The main questions to be answered are: 1. People with what etiologies benefit most from access to the voice-activated call light system? 2. How reliable is the voice-activated call light system in alerting staff to a client's need for assistance? 3. How confident are clients, family members, and staff in the reliability of the voice-activated system for alerting staff of a client's need for assistance? 4. How does access to the voice-activated call light system compare to traditional call light systems regarding staff effort and disruption to routine care? Participants with limited upper extremity movement will use the voice-activated call light system as needed during normal daily activities for up to 90 days. At study initiation, clients with limited upper extremity movement, staff members working with those clients, and family members of the clients will complete a brief questionnaire about their experiences using the existing call light system. At approximately Days 30, 60, and 90, they will complete brief questionnaires about use of the voice-activated call light system and its effectiveness.
Study identification
- NCT ID
- NCT07873151
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 19 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2026 (Estimated)
- Primary completion
- Dec 31, 2027 (Estimated)
- Completion
- Dec 31, 2027 (Estimated)
- Last update posted
- Oct 14, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Quality Living, Inc. | Omaha | Nebraska | 68804 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07873151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07873151 live on ClinicalTrials.gov.